DOCSLIB.ORG

Framework for Equitable Allocation of COVID-19 Vaccine (2020)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

THE NATIONAL ACADEMIES PRESS This PDF is available at http://nap.edu/25917 SHARE Framework for Equitable Allocation of COVID-19 Vaccine (2020) DETAILS 260 pages | 6 x 9 | PAPERBACK ISBN 978-0-309-68224-4 | DOI 10.17226/25917 CONTRIBUTORS GET THIS BOOK Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors; Committee on Equitable Allocation of Vaccine for the Novel Coronavirus; Board on Health Sciences Policy; Board on Population Health and Public Health Practice; Health FIND RELATED TITLES and Medicine Division; National Academies of Sciences, Engineering, and Medicine; National Academy of Medicine SUGGESTED CITATION National Academies of Sciences, Engineering, and Medicine 2020. Framework for Equitable Allocation of COVID-19 Vaccine. Washington, DC: The National Academies Press. https://doi.org/10.17226/25917. Visit the National Academies Press at NAP.edu and login or register to get: – Access to free PDF downloads of thousands of scientific reports – 10% off the price of print titles – Email or social media notifications of new titles related to your interests – Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. (Request Permission) Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Copyright © National Academy of Sciences. All rights reserved. Framework for Equitable Allocation of COVID-19 Vaccine Framework for Equitable Allocation of COVID-19 Vaccine Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors Committee on Equitable Allocation of Vaccine for the Novel Coronavirus Board on Health Sciences Policy Board on Population Health and Public Health Practice Health and Medicine Division PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright National Academy of Sciences. All rights reserved. Framework for Equitable Allocation of COVID-19 Vaccine THE NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001 This activity was supported by contracts between the National Academy of Sciences and the Centers for Disease Control and Prevention and the National Institutes of Health (75N98020F00007). This project has been funded in whole or in part with federal funds from the Office of Science Policy, National Institutes of Health, U.S. Department of Health and Human Services under Contract No. HHSN263201800029I. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. International Standard Book Number-13: 978-0-309-XXXXX-X International Standard Book Number-10: 0-309-XXXXX-X Digital Object Identifier: https://doi.org/10.17226/25917 Additional copies of this publication are available from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu. Copyright 2020 by the National Academy of Sciences. All rights reserved. Printed in the United States of America Suggested citation: National Academies of Sciences, Engineering, and Medicine. 2020. Framework for equitable allocation of COVID-19 vaccine. Washington, DC: The National Academies Press. https://doi.org/10.17226/25917. PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright National Academy of Sciences. All rights reserved. Framework for Equitable Allocation of COVID-19 Vaccine The National Academy of Sciences was established in 1863 by an Act of Congress, signed by President Lincoln, as a private, nongovernmental institution to advise the nation on issues related to science and technology. Members are elected by their peers for outstanding contributions to research. Dr. Marcia McNutt is president. The National Academy of Engineering was established in 1964 under the charter of the National Academy of Sciences to bring the practices of engineering to advising the nation. Members are elected by their peers for extraordinary contributions to engineering. Dr. John L. Anderson is president. The National Academy of Medicine (formerly the Institute of Medicine) was established in 1970 under the charter of the National Academy of Sciences to advise the nation on medical and health issues. Members are elected by their peers for distinguished contributions to medicine and health. Dr. Victor J. Dzau is president. The three Academies work together as the National Academies of Sciences, Engineering, and Medicine to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science, engineering, and medicine. Learn more about the National Academies of Sciences, Engineering, and Medicine at www.nationalacademies.org. PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright National Academy of Sciences. All rights reserved. Framework for Equitable Allocation of COVID-19 Vaccine Consensus Study Reports published by the National Academies of Sciences, Engineering, and Medicine document the evidence-based consensus on the study’s statement of task by an authoring committee of experts. Reports typically include findings, conclusions, and recommendations based on information gathered by the committee and the committee’s deliberations. Each report has been subjected to a rigorous and independent peer-review process and it represents the position of the National Academies on the statement of task. Proceedings published by the National Academies of Sciences, Engineering, and Medicine chronicle the presentations and discussions at a workshop, symposium, or other event convened by the National Academies. The statements and opinions contained in proceedings are those of the participants and are not endorsed by other participants, the planning committee, or the National Academies. For information about other products and activities of the National Academies, please visit www.nationalacademies.org/about/whatwedo. PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright National Academy of Sciences. All rights reserved. Framework for Equitable Allocation of COVID-19 Vaccine COMMITTEE ON EQUITABLE ALLOCATION OF VACCINE FOR THE NOVEL CORONAVIRUS WILLIAM H. FOEGE (Co-Chair), Emeritus Distinguished Professor of International Health, Rollins School of Public Health, Emory University HELENE D. GAYLE (Co-Chair), President and Chief Executive Officer, The Chicago Community Trust MARGARET L. BRANDEAU, Coleman F. Fung Professor of Engineering, Professor of Medicine (by courtesy), Department of Management Science and Engineering, Stanford University ALISON M. BUTTENHEIM, Associate Professor of Nursing and Health Policy, University of Pennsylvania School of Nursing R. ALTA CHARO, Warren P. Knowles Professor of Law and Bioethics, University of Wisconsin Law School JAMES F. CHILDRESS, University Professor Emeritus, Institute for Practical Ethics and Public Life, University of Virginia ANA V. DIEZ ROUX, Dean and Distinguished University Professor of Epidemiology, Dornsife School of Public Health, Drexel University ABIGAIL ECHO-HAWK (Citizen of the Pawnee Nation), Director, Urban Indian Health Institute, Chief Research Officer, Seattle Indian Health Board CHRISTOPHER ELIAS, President, Global Development Division, Bill & Melinda Gates Foundation BARUCH FISCHHOFF, Howard Heinz University Professor, Department of Engineering and Public Policy, Institute for Politics and Strategy, Carnegie Mellon University DAVID MICHAELS, Professor, Environmental and Occupational Health, Milken Institute School of Public Health, The George Washington University JEWEL MULLEN, Associate Dean for Health Equity, Associate Professor of Population Health and Internal Medicine, The University of Texas at Austin Dell Medical School SAAD B. OMER, Director, Yale Institute for Global Health DANIEL POLSKY, Bloomberg Distinguished Professor of Health Policy and Economics, Carey Business School and Bloomberg School of Public Health, Johns Hopkins University SONJA RASMUSSEN, Professor of Pediatrics, Epidemiology, and Obstetrics and Gynecology, College of Medicine and College of Public Health and Health Professions, University of Florida ARTHUR L. REINGOLD, Division Head, Epidemiology and Biostatistics, Professor of Epidemiology, School of Public Health, University of California, Berkeley REED V. TUCKSON, Managing Director, Tuckson Health Connections, LLC MICHAEL R. WASSERMAN, President, California Association of Long Term Care Medicine Study Staff LISA BROWN, Study Director BENJAMIN KAHN, Associate Program Officer ELIZABETH FINKELMAN, Senior Program Officer AURELIA ATTAL-JUNCQUA, Associate Program Officer PREPUBLICATION COPY: UNCORRECTED PROOFS v Copyright National Academy of Sciences. All rights reserved. Framework for Equitable Allocation of COVID-19 Vaccine EMMA FINE, Associate Program Officer REBECCA CHEVAT, Senior Program Assistant ROSE MARIE MARTINEZ, Senior Director, Board on Population Health and Public Health Practice ANDREW M. POPE, Senior Director, Board on Health Sciences Policy Science Writer ANNA NICHOLSON PREPUBLICATION COPY: UNCORRECTED PROOFS vi Copyright National Academy of Sciences. All rights reserved. Framework for Equitable Allocation of COVID-19 Vaccine Reviewers This Consensus Study Report was reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise.
Recommended publications
  • From the Factory to the Frontlines the Operation Warp Speed Strategy for Distributing a COVID-19 Vaccine

    From the Factory to the Frontlines the Operation Warp Speed Strategy for Distributing a COVID-19 Vaccine

    From the Factory to the Frontlines The Operation Warp Speed Strategy for Distributing a COVID-19 Vaccine What This Strategy Aims to Do This report to Congress details a strategy to achieve the principal purpose and objective of Operation Warp Speed (OWS): ensuring that every American who wants to receive a COVID-19 vaccine can receive one, by delivering safe and effective vaccine doses to the American people beginning January 2021. The leadership of OWS has committed to being transparent with Congress, the media, and the American people. OWS has provided regular briefings on topics of interest to Congress and the media and will continue to provide updates and announcements as OWS reaches new milestones. Congress has been a vital partner in the all-of-America response to the COVID-19 pandemic. With support provided through emergency supplemental and flexible discretionary funding, OWS has now made strong progress toward a safe and effective COVID-19 vaccine, with multiple candidates in Phase 3 clinical trials. Simultaneously, OWS and partners are developing a plan for delivering a safe and effective product to Americans as quickly and reliably as possible. Experts from the Department of Health and Human Services (HHS) are leading vaccine development, while experts from the Department of Defense (DoD) are partnering with the Centers for Disease Control and Prevention (CDC) and other parts of HHS to coordinate supply, production, and distribution of vaccines. Successful implementation of the national COVID-19 vaccination program requires precise coordination across federal, state, local, tribal, and territorial governments and among many public and private partners.
  • J. Michael Mcginnis, Md, Ma, Mpp

    J. Michael Mcginnis, Md, Ma, Mpp

    J. MICHAEL MCGINNIS, MD, MA, MPP National Academy of Medicine, the National Academies, 500 Fifth Street NW, Washington DC 20001, (202) 334-3963, [email protected] Highlights: Michael McGinnis is a physician and epidemiologist who lives and works in Washington DC. Through his writing, government service, and work in philanthropy, he has been a long-time contributor to national and international field leadership in health, health care, and health policy. He currently serves at the National Academy of Medicine (NAM), where he is the Leonard D. Schaeffer Executive Officer, Senior Scholar, and Executive Director of the NAM’s Leadership Consortium for public and private collaboration on behalf of a continuously learning health system. Previously, he served as founding Director, respectively, of the Robert Wood Johnson Foundation’s (RWJF) Health Group, the World Health Organization’s Office for Health Reconstruction in Bosnia, the federal Office of Research Integrity (interim), and the federal Office of Disease Prevention and Health Promotion. In a tenure unusual for political and policy posts, he held continuous appointment through the Carter, Reagan, Bush and Clinton Administrations at the Department of Health and Human Services, with policy responsibilities for disease prevention and health promotion (1977-1995). Programs and policies conceived and launched at his initiative include the Healthy People process establishing national health goals and objectives (1979-present), the U.S. Preventive Services Task Force (1984-present), the Dietary Guidelines for Americans (with USDA, 1980- present), the multi-level Public Health Functions Steering Group and the Ten Essential Services of Public Health (1994-present), the RWJF Active Living family of programs (2000-present), the RWJF Young Epidemiology Scholars Program (2001-2012), the RWJF Health and Society Scholars Program (2002-2017), and the current Learning Health System initiative of the NAM.
  • OAKLAND COUNTY DIRECTORY 2016 Oakland County Directory Lisa Brown - Oakland County Clerk/Register of Deeds Experience Oakgov.Com/Clerkrod 2016

    OAKLAND COUNTY DIRECTORY 2016 Oakland County Directory Lisa Brown - Oakland County Clerk/Register of Deeds Experience Oakgov.Com/Clerkrod 2016

    OAKLAND COUNTY DIRECTORY 2016 Oakland County Directory Lisa Brown - Oakland County Clerk/Register of Deeds Experience oakgov.com/clerkrod 2016 Get Fit! Seven parks offer natural and paved trails for hiking, biking and equestrians. From Farm to Family Oakland County Market offers grower-direct fresh produce and flowers year-round from more than 140 farmers and artisans representing 17 Michigan counties. Get Outdoors Cool Off Camp Learn to golf at five courses! Season Passes for two waterparks. With Family and friends. Visit DestinationOakland.com About the Front Cover An art contest was held by Oakland County Clerk/Register of Deeds Lisa Brown that was open to all high school students who live and attend school in Oakland County. Students made original works of art depicting the theme of “The Importance of Voting.” The winning art piece, shown on the cover, was created by Kate Donoghue of Sylvan Lake. “Through my picture, I tried to portray that if you have the ability to vote but do not take the opportunity to do it, your thoughts and opinions will never be represented,” said Kate. She added, “I think that it is very important to vote if you have the chance to do so because your beliefs and the decision making ability of others could determine your future.” Kate used Sharpies and watercolor pencils to create her artwork. Congratulations, Kate! Lisa Brown OAKLAAND COUNTY CLERK/REGISTER OF DEEDS www.oakgov.com/clerkrod Dear Oakland County County Resident: Resident: II’m'm honoredhonored toto serveserve as as your your Clerk/Register Clerk/Register of ofDeeds.
  • Administration of Donald J. Trump, 2020 Remarks on Coronavirus

    Administration of Donald J. Trump, 2020 Remarks on Coronavirus

    Administration of Donald J. Trump, 2020 Remarks on Coronavirus Vaccine Development November 13, 2020 The President. Thank you very much. Thank you. It's beautiful out here this time of year. In the past 9 months, my administration has initiated the single greatest mobilization in U.S. history, pioneering, developing, and manufacturing therapies and vaccines in record time. Numbers like nobody has seen before. No medical breakthrough of this scope and magnitude has ever been achieved this rapidly, this quickly. And we're very proud of it, and I had tremendous help from the military—generals, admirals—and many of the great people at the White House. Operation Warp Speed is unequaled and unrivaled anywhere in the world, and leaders of other countries have called me to congratulate us on what we've been able to do, and we've helped many countries with their ventilators and all of the problems they were having. And I'd like to congratulate everyone involved in this effort. It's been an incredible effort. As a result of Operation Warp Speed, Pfizer announced on Monday that its "China virus" vaccine is more than 90-percent effective. This far exceeds any and all expectations. Nobody thought they'd get to that level. And we have others coming which we think will be at equal level—maybe more, if that's possible. In July, my administration reached an agreement with Pfizer to provide $1.95 billion to support the mass manufacturing and distribution of 100 million doses, with the option to purchase a total of 600 million doses shortly thereafter.
  • Case 1:21-Cv-00756 ECF No. 1, Pageid.1 Filed 08/27/21 Page 1 of 49

    Case 1:21-Cv-00756 ECF No. 1, Pageid.1 Filed 08/27/21 Page 1 of 49

    Case 1:21-cv-00756 ECF No. 1, PageID.1 Filed 08/27/21 Page 1 of 49 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF MICHIGAN JEANNA NORRIS, on behalf of herself ) and all others similarly situated, ) ) Plaintiffs, ) ) v. ) ) CLASS ACTION COMPLAINT SAMUEL L. STANLEY, JR. ) FOR DECLARATORY AND in his official capacity as President of ) INJUNCTIVE RELIEF Michigan State University; DIANNE ) BYRUM, in her official capacity as Chair ) JURY TRIAL DEMANDED of the Board of Trustees, DAN KELLY, ) in his official capacity as Vice Chair ) of the Board of Trustees; and RENEE ) JEFFERSON, PAT O’KEEFE, ) BRIANNA T. SCOTT, KELLY TEBAY, ) and REMA VASSAR, in their official ) capacities as Members of the Board of ) Trustees of Michigan State University, ) and JOHN and JANE DOES 1-10, ) ) Defendants. ) Plaintiff and those similarly situated, by and through their attorneys at the New Civil Liberties Alliance (“NCLA”), hereby complains and alleges the following: INTRODUCTORY STATEMENT a. By the spring of 2020, the novel coronavirus SARS-CoV-2, which can cause the disease COVID-19, had spread across the globe. Since then, and because of the federal government’s “Operation Warp Speed,” three separate coronavirus vaccines have been developed and approved more swiftly than any other vaccines in our nation’s history. The Food and Drug Administration (“FDA”) issued an Emergency Use Authorization (“EUA”) for the Pfizer- 1 Case 1:21-cv-00756 ECF No. 1, PageID.2 Filed 08/27/21 Page 2 of 49 BioNTech COVID-19 Vaccine (“BioNTech Vaccine”) on December 11, 2020.1 Just one week later, FDA issued a second EUA for the Moderna COVID-19 Vaccine (“Moderna Vaccine”).2 FDA issued its most recent EUA for the Johnson & Johnson COVID-19 Vaccine (“Janssen Vaccine”) on February 27, 2021 (the only EUA for a single-shot vaccine).3 b.
  • COVID-19 UPDATE November 23, 2020 Global Total Cases – 59,025,871 Total Deaths – 1,393,889

    COVID-19 UPDATE November 23, 2020 Global Total Cases – 59,025,871 Total Deaths – 1,393,889

    COVID-19 UPDATE November 23, 2020 Global Total cases – 59,025,871 Total deaths – 1,393,889 United States Total cases – 12,369,978 Total deaths – 257,415 On Wednesday, the United States surpassed 250,000 coronavirus deaths. The total number of patients hospitalized with COVID-19 in the United States has reached new highs every day since November 11, when hospitalizations first surpassed the April peak. One week before the end of the month, the United States has already recorded its highest monthly case total in November, reporting more than 3,075,000 cases. The number of November cases could exceed four million, more than double the total in October. Trump Administration • The Centers for Disease Control and Prevention urged Americans against traveling for Thanksgiving and to limit gatherings to people in the same household as Covid-19 rages in the U.S. o “Celebrating virtually or with the people you live with is the safest choice this Thanksgiving,” the agency said on its website on Thursday. “Travel may increase your chance of getting and spreading COVID-19.” o For people considering traveling for the holiday, the agency offered a checklist of risks and standard advice such as wearing a face covering and staying 6 feet away from people “who don’t live with you.” People hosting Thanksgiving guests at home should observe precautions that could include having an outdoor meal with family and friends, have people bring their own food and drink, and opening windows if the gathering is indoors. • In a call last week, Centers for Disease Control and Prevention Director Robert Redfield and Health and Human Services Secretary Alex Azar encouraged governors to help build confidence in vaccines and stressed the importance of wearing masks.
  • THE SURGEON GENERAL and the BULLY PULPIT Michael Stobbe a Dissertation Submitted to the Faculty of the University of North Carol

    THE SURGEON GENERAL and the BULLY PULPIT Michael Stobbe a Dissertation Submitted to the Faculty of the University of North Carol

    THE SURGEON GENERAL AND THE BULLY PULPIT Michael Stobbe A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Public Health in the Department of Health Policy and Administration, School of Public Health Chapel Hill 2008 Approved by: Ned Brooks Jonathan Oberlander Tom Ricketts Karl Stark Bryan Weiner ABSTRACT MIKE STOBBE: The Surgeon General and the Bully Pulpit (Under the direction of Ned Brooks) This project looks at the role of the U.S. Surgeon General in influencing public opinion and public health policy. I examined historical changes in the administrative powers of the Surgeon General, to explain what factors affect how a Surgeon General utilizes the office’s “bully pulpit,” and assess changes in the political environment and in who oversees the Surgeon General that may affect the Surgeon General’s future ability to influence public opinion and health. This research involved collecting and analyzing the opinions of journalists and key informants such as current and former government health officials. I also studied public documents, transcripts of earlier interviews and other materials. ii TABLE OF CONTENTS LIST OF TABLES.................................................................................................................v Chapter 1. INTRODUCTION ...............................................................................................1 Background/Overview .........................................................................................1
  • Emerging Leaders in Biosecurity Initiative

    Emerging Leaders in Biosecurity Initiative

    Emerging Leaders in Biosecurity Initiative Class of 2017 A competitive fellowship program created to identify, develop, and provide networking opportunities Yearbook for the next generation of leaders in biosecurity. Emerging Leaders in Biosecurity Initiative Contents Letter: 3 Thomas V. Inglesby, Director; Anita Cicero, Deputy Director, Johns Hopkins Center for Health Security Executive Steering Committee 5 Class of 2017 Fellows 9-35 ELBI 2017 Year in Review 36-37 ELBI Program Staff 41 ELBI Alumni 42 Cover and Inside Cover Photo Overlay: Swine Flu Strain Virus Particles. Col- orized transmission electron micrograph of negatively stained SW31 (swine strain) influenza virus particles. Credit: NIAID Emerging Leaders in Biosecurity Initiative The ELBI Fellowship program is made possible through financial support from the Open Philanthropy Project, under management by the Johns Hopkins Center for Health Security, and with the leadership of the ELBI Executive Steering Committee. For more information, please visit the ELBI website: http://www.centerforhealthsecurity.org/our-work/emergingbioleaders Center for Health Security “Modern conditions make the scenario of a global pandemic more likely. Humans are encroaching on animal environments, raising chances for pathogens to adapt from animals to people. An increasing share of the planet lives in megacities, heightening the likelihood of person-to-person transmission of pathogens. The movement of people and microbes around the globe is more efficient than ever. The recent outbreaks of SARS, MERS, and Ebola are only small glimpses of how quickly a deadly virus can spread.” Tom Inglesby and Benjamin Haas Foreign Affairs November 21, 2017 Middle East Respiratory Syndrome Coronavirus particle envelope proteins immunolabeled with Rabbit HCoV-EMC/2012 primary antibody and Goat an- 1 ti-Rabbit 10 nm gold particles.
  • SYRA MADAD, D.H.Sc, M.Sc., MCP

    SYRA MADAD, D.H.Sc, M.Sc., MCP

    SYRA MADAD, D.H.Sc, M.Sc., MCP Syra Madad, D.H.Sc., M.Sc., MCP is nationally recognized leader in public health and special pathogen preparedness and response. She is Senior Director, System-wide Special Pathogens Program at New York City Health + Hospitals, the nation’s largest municipal healthcare delivery system overseeing special pathogen preparedness and response efforts across 11 acute care hospitals in addition to post-acute/long-term care facilities and ambulatory care sites. She is Principal Investigator of NYC Health + Hospitals Center for Global Healthcare Preparedness to Special Pathogens. In addition, Dr. Madad is Core Faculty in the National Ebola Training and Education Center (NETEC), funded by the Centers for Disease Control and Prevention (CDC) and the Assistant Secretary for Preparedness and Response (ASPR) and Assistant Professor in the Graduate Biotechnology/Biodefense Program at the University of Maryland. She is an Alumni Fellow at Johns Hopkins Bloomberg School of Public Health, Center for Health Security’s Emerging Leaders in Biosecurity Program and the Federal Bureau of Investigation’s Behavioral Informatics & Technological Enterprise Studies Program. Dr. Madad earned her Doctoral degree in Health Science with a concentration in Global Health from Nova Southeastern University, graduating with Alpha Eta Health Science Honor Society status. She obtained her Master of Science degree in Biotechnology with a concentration in Biodefense and Biosecurity and Bachelor of Science degree in Psychology from the University of Maryland. Dr. Madad holds numerous professional certifications, licenses and training certificates including Master Continuity Practitioner Certification (FEMA), Advanced Emergency Planning Certification, All Hazard Response (CBRNE) Training for Laboratory Personnel, Biosafety Level III Training, and Identification of the Primary Select Agents of Bioterrorism Training.
  • 2006-07 Annual Report

    2006-07 Annual Report

    ����������������������������� the chicago council on global affairs 1 The Chicago Council on Global Affairs, founded in 1922 as The Chicago Council on Foreign Relations, is a leading independent, nonpartisan organization committed to influencing the discourse on global issues through contributions to opinion and policy formation, leadership dialogue, and public learning. The Chicago Council brings the world to Chicago by hosting public programs and private events featuring world leaders and experts with diverse views on a wide range of global topics. Through task forces, conferences, studies, and leadership dialogue, the Council brings Chicago’s ideas and opinions to the world. 2 the chicago council on global affairs table of contents the chicago council on global affairs 3 Message from the Chairman The world has undergone On September 1, 2006, The Chicago Council on tremendous change since Foreign Relations became The Chicago Council on The Chicago Council was Global Affairs. The new name respects the Council’s founded in 1922, when heritage – a commitment to nonpartisanship and public nation-states dominated education – while it signals an understanding of the the international stage. changing world and reflects the Council’s increased Balance of power, national efforts to contribute to national and international security, statecraft, and discussions in a global era. diplomacy were foremost Changes at The Chicago Council are evident on on the agenda. many fronts – more and new programs, larger and more Lester Crown Today, our world diverse audiences, a step-up in the pace of task force is shaped increasingly by forces far beyond national reports and conferences, heightened visibility, increased capitals.
  • So Many People Are Perplexed with the Covid-19 Lockdowns, Mask Requirements, Social Distancing, Loss of Jobs, Homes, and Their Very Sanity

    So Many People Are Perplexed with the Covid-19 Lockdowns, Mask Requirements, Social Distancing, Loss of Jobs, Homes, and Their Very Sanity

    So many people are perplexed with the Covid-19 lockdowns, mask requirements, social distancing, loss of jobs, homes, and their very sanity. What lies behind all of this? There have been so many conflicting reports that one has to ask the question, Is there even a pandemic at all? Was there ever one? Let’s have a look. ======================== Strange advance hints (predictive programming) – A 1993 Simpsons episode called “Marge in Chains” actually accurately predicted the coronavirus outbreak. One scene depicted a boardroom meeting between government officials and major media moguls. The chairman opened with these words: “I’d like to call to order this secret conclave of America’s media empires. We are here to come up with the next phony baloney crisis to put Americans back where they belong…” Suddenly a delegate from NBC chimed in: “Well I think…” Then the chairman interrupted him, saying: “NBC, you are here to listen and not speak!” He then said: “I think we should go with a good old fashioned health scare.” Everyone then nodded in approval. Next, a female delegate remarked: “A new disease–no one’s immune–it’s like The Summer of the Shark, except instead of the shark, it’s an epidemic.” – Another Simpsons episode called “A Totally Fun Thing that Bart will Never Do Again,” first aired on April 29, 2012, featured an emergency broadcast announcing the outbreak of the deadly “Pandora Virus,” and how it was “spreading rapidly.” The announcer then said: “This unprecedented threat requires a world-wide quarantine. All ships must remain at sea until further notice.
  • THE SURGEON GENERAL and the BULLY PULPIT Michael Stobbe a Dissertation Submitted to the Faculty of the University of North Carol

    THE SURGEON GENERAL and the BULLY PULPIT Michael Stobbe a Dissertation Submitted to the Faculty of the University of North Carol

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Carolina Digital Repository THE SURGEON GENERAL AND THE BULLY PULPIT Michael Stobbe A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Public Health in the Department of Health Policy and Administration, School of Public Health Chapel Hill 2008 Approved by: Ned Brooks Jonathan Oberlander Tom Ricketts Karl Stark Bryan Weiner ABSTRACT MIKE STOBBE: The Surgeon General and the Bully Pulpit (Under the direction of Ned Brooks) This project looks at the role of the U.S. Surgeon General in influencing public opinion and public health policy. I examined historical changes in the administrative powers of the Surgeon General, to explain what factors affect how a Surgeon General utilizes the office’s “bully pulpit,” and assess changes in the political environment and in who oversees the Surgeon General that may affect the Surgeon General’s future ability to influence public opinion and health. This research involved collecting and analyzing the opinions of journalists and key informants such as current and former government health officials. I also studied public documents, transcripts of earlier interviews and other materials. ii TABLE OF CONTENTS LIST OF TABLES.................................................................................................................v Chapter 1. INTRODUCTION ...............................................................................................1